Pharmafile Logo
Pharmafocus logo
Advanced Search
Abbvie image

AbbVie and Galapagos extend deal

May 21, 2013
Sales and Marketing AbbVie, Crohn's, Galapagos

AbbVie and Belgian biotech Galapagos have bolted on a development programme for Crohn’s disease to the selective JAK1 inhibitor they …

News
NHS image

Working with the NHS in austerity

May 20, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, atkin, austerity, reforms, wellards

The National Health Service, perhaps the UK’s most deeply loved institution, is facing a double threat. On one hand, there …

Feature

Promise for Lundbeck and Takeda’s depression drug

May 20, 2013
Research and Development, Sales and Marketing Lexapro, Lundbeck, Takeda, cymbalta, depression, lilly

Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …

News
kela-madar

Biotec Services expands presence in Israel

May 20, 2013
Research and Development, Sales and Marketing Biotec

Clinical supplies firm Biotec Services International has expanded its presence in Israel with the appointment of a new Israeli agent. …

Appointment

Excipient certification scheme launches in US

May 17, 2013
Manufacturing and Production EXCiPACT, GMP

A certification scheme for pharmaceutical excipients to make it easier for drugmakers to source materials from reliable suppliers made its …

News
rawlins_nice

NICE chairman joins biotech Board

May 17, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Intra-Cellular Therapies, NICE, Rawlins

Biotech firm Intra-Cellular Therapies has appointed former NICE chairman Professor Sir Michael Rawlins to its Board of directors. Rawlins was …

Appointment

South Korea eyeing criminal charges over J&J plant failures

May 17, 2013
Manufacturing and Production J&J, JJ, Janssen, Korea, MFDS

The chief executive of Johnson & Johnson’s South Korean subsidiary could be facing criminal charges over quality lapses at a …

News

Government ‘joins-up’ system

May 15, 2013
Sales and Marketing NHS, NICE, government, king's fund

The government has launched its plans to create ‘a truly joined-up system’ for the provision of health and social care …

News
Elan image

Elan signs $1 billion finance deal with Theravance

May 15, 2013
Research and Development, Sales and Marketing Elan, Theravance, royalty pharma

Elan has struck a novel deal with Theravance which gives it a share of potential future royalties from its respiratory …

News
sumant_hospira__033retoucha

Hospira Reappoints chief scientific officer

May 15, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Hospira

Injectable drugs and infusion tech firm Hospira has announced that Sumant Ramachandra has been reappointed to his role as senior …

Appointment
Pfizer image

Pfizer targets Newcastle

May 15, 2013
Research and Development, Sales and Marketing ABPI, Cameron, NHS, Newcastle, Pfizer

Pfizer has earmarked Newcastle Hospitals NHS Foundation Trust as one of 60 sites worldwide to take part in a key …

News
Amgen image

Amgen and Zhejiang sign cancer deal

May 14, 2013
Sales and Marketing Amgen, Cancer, Zhejiang

Amgen has signed a joint venture deal with Chinese firm Zhejiang Beta Pharma to commercialise oncology drug Vectibix. The companies …

News

Optimer Pharmaceuticals appoints chief operating officer

May 14, 2013
Manufacturing and Production, Research and Development, Sales and Marketing

Biopharma firm Optimer Pharmaceuticals has announced the appointment of Eric Sirota as chief operating officer.  “Eric has tremendous experience and …

Appointment
Ranbaxy image

Ranbaxy unit fined $500m for selling adulterated drugs

May 14, 2013
Manufacturing and Production FDA, GMP, Ranbaxy, fine, generics

Ranbaxy’s US subsidiary has agreed to pay fines and penalties totalling $500 million after pleading guilty to charges of manufacturing …

News
EMA image

EMA ponders biosimilar guideline

May 14, 2013
Research and Development, Sales and Marketing EMA, biosimilars

The European Medicines Agency is thinking about changes to its guidance on similar biological medicines and has published a draft …

News
Lilly image

Lilly takes $30m hit

May 13, 2013
Research and Development, Sales and Marketing enzastaurin, lilly

Eli Lilly has taken a $30 million hit after abandoning late-stage development of its investigational cancer drug enzastaurin. The compound …

News
NHS image

Francis at centre of Care Bill

May 13, 2013
Sales and Marketing Hunt, Mid Staffs, NHS

The government’s new Care Bill carries a variety of measures designed to ensure that failings such as those at the …

News

John LaMattina: India’s solution to drug costs

May 13, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, LaMattina, R&D

Drug pricing is a major issue in India. The Indian government believes that the prices of lifesaving drugs shouldn’t be …

Feature

New Board member for Misonix

May 13, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Misonix

Surgical device company Misonix has announced that Stavros Vizirgianakis has been appointed to its Board of directors.The addition of Vizirgianakis …

Appointment
Takeda image

Takeda to buy Inviragen

May 10, 2013
Research and Development, Sales and Marketing Inviragen, Takeda

Takeda has hit the acquisition trail, putting together a $250 million package to buy private US biopharma firm Inviragen in …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026